newsare.net
German pharmaceutical giant Bayer is running into mounting shareholder opposition ahead of its annual meeting on Friday. The company’s investors are faulting management for failing to foresee the risks of its biggest deal ever. Read Full Article at RT.comBayer bosses facing shareholder reckoning over Monsanto deal as cancer lawsuits mount
German pharmaceutical giant Bayer is running into mounting shareholder opposition ahead of its annual meeting on Friday. The company’s investors are faulting management for failing to foresee the risks of its biggest deal ever. Read Full Article at RT.com Read more